BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29806632)

  • 1. Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg mice.
    Seki T; Miyamoto A; Ohshima S; Ohno Y; Yasuda A; Tokuda Y; Ando K; Kametani Y
    Biosci Trends; 2018 Jul; 12(3):247-256. PubMed ID: 29806632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
    PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.
    Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T
    Front Immunol; 2018; 9():152. PubMed ID: 29456539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice.
    Ohno Y; Ohshima S; Miyamoto A; Kametani F; Ito R; Tsuda B; Kasama Y; Nakada S; Kashiwagi H; Seki T; Yasuda A; Ando K; Ito M; Tokuda Y; Kametani Y
    Sci Rep; 2021 Jun; 11(1):12798. PubMed ID: 34140620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
    Verma B; Wesa A
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
    Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
    Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses.
    Yaguchi T; Kobayashi A; Inozume T; Morii K; Nagumo H; Nishio H; Iwata T; Ka Y; Katano I; Ito R; Ito M; Kawakami Y
    Cell Mol Immunol; 2018 Nov; 15(11):953-962. PubMed ID: 29151581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9.
    Ka Y; Katano I; Nishinaka E; Welcker J; Mochizuki M; Kawai K; Goto M; Tomiyama K; Ogura T; Yamamoto T; Ito M; Ito R; Takahashi R
    Immunol Lett; 2021 Jan; 229():55-61. PubMed ID: 33253759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
    Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
    Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
    Katano I; Ito R; Eto T; Aiso S; Ito M
    Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4
    Ito R; Katano I; Kawai K; Yagoto M; Takahashi T; Ka Y; Ogura T; Takahashi R; Ito M
    Am J Transplant; 2017 May; 17(5):1216-1228. PubMed ID: 27862942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
    J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of the human CD4⁺ T-cell response in humanized HLA-DR4-expressing NOD/Shi-scid/γc(null) (NOG) mice by retrogenic expression of the human TCR gene.
    Takahashi T; Katano I; Ito R; Ito M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):219-24. PubMed ID: 25462565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
    Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
    J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
    Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
    Front Immunol; 2018; 9():601. PubMed ID: 29628927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
    Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
    Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.